Analyst Ratings for Emerson (EMR)
EMR Rating Summary
EMR Price Target Summary
- Highest: $1,500.00 (TD Cowen)
- Lowest: $125.00 (Morgan Stanley)
- Average: $241.41
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$241.41 (+74.5%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
Avg. $ Target:
$241.41 (+74.5%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/4/2026 | Deutsche Bank | Nicole DeBlase | Downgrade | Hold (Buy) |
170.00 (N/A) |
152.10 (138.36) |
-9.03% | Details |
| 1/27/2026 | Oppenheimer | Christopher Glynn | Downgrade | Perform (Outperform) |
N/A (N/A) |
147.68 (138.36) |
-6.31% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
